Viewing Study NCT00791895


Ignite Creation Date: 2025-12-24 @ 2:01 PM
Ignite Modification Date: 2026-04-16 @ 5:26 AM
Study NCT ID: NCT00791895
Status: COMPLETED
Last Update Posted: 2017-02-24
First Post: 2008-11-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs
Sponsor: Novo Nordisk A/S
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: BIASP-2174
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators